Earnings Feed
Start Free
Home/Filings/4/0000899243-21-042467
4//SEC Filing

McDonough Brian 4

Accession 0000899243-21-042467

CIK 0001596946other
View on SEC.govCompany Profile

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 7:06 PM ET

Size

24.8 KB

Accession

0000899243-21-042467

Insider Transaction Report

Form 4
Period: 2021-10-31
Quotient LtdQTNT
McDonough Brian
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-10-31+3,847→ 63,106 total
  • Award

    Ordinary Share Option (Right to Buy)

    2021-10-31+24,040→ 24,040 total
    Exercise: $2.53Exp: 2031-10-31→ Ordinary Shares (24,040 underlying)
  • Award

    Restricted Stock Units

    2021-10-31+27,668→ 27,668 total
    → Ordinary Shares (27,668 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2021-10-31−3,847→ 0 total
    → Ordinary Shares (3,847 underlying)
Holdings

  • Ordinary Shares Option (Right to buy)

    Exercise: $8.00Exp: 2024-04-29→ Ordinary Shares (10,000 underlying)
    10,000

  • Ordinary Shares Option (Right to buy)

    Exercise: $5.73Exp: 2026-10-31→ Ordinary Shares (8,726 underlying)
    8,726

  • Ordinary Shares Option (Right to buy)

    Exercise: $6.41Exp: 2028-10-31→ Ordinary Shares (6,240 underlying)
    6,240

  • Ordinary Shares Option (Right to buy)

    Exercise: $7.78Exp: 2029-10-31→ Ordinary Shares (8,158 underlying)
    8,158

  • Ordinary Shares

    (indirect: By Trust)
    53,040

  • Ordinary Shares Option (Right to buy)

    Exercise: $5.21Exp: 2027-10-31→ Ordinary Shares (9,597 underlying)
    9,597

  • Ordinary Shares Option (Right to buy)

    Exercise: $9.95Exp: 2024-10-31→ Ordinary Shares (5,025 underlying)
    5,025

  • Options to purchase ordinary shares

    From: 2014-11-14Exp: 2022-08-30→ Ordinary Shares (40,029 underlying)
    40,029

  • Ordinary Shares Option (Right to buy)

    Exercise: $11.62Exp: 2025-10-31→ Ordinary Shares (4,303 underlying)
    4,303

  • Ordinary Share Option (Right to Buy)

    Exercise: $4.55Exp: 2030-10-31→ Ordinary Shares (13,611 underlying)
    13,611
Footnotes (14)
  • [F1]All 10,000 options have vested and remain exercisable.
  • [F10]2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
  • [F11]On October 31, 2020, the Reporting Person was granted 15,385 restricted stock units, all of which have vested and have been exercised.
  • [F12]All 13,611 options have vested and remain exercisable.
  • [F13]On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, vesting in four equal installments on January 31, 2022, April 30, 2022, July 31, 2022 and October 31, 2022.
  • [F14]The options vest and become exercisable on October 31, 2022.
  • [F2]The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
  • [F3]All 5,025 options have vested and remain exercisable.
  • [F4]All 4,303 options have vested and remain exercisable.
  • [F5]All 8,726 options have vested and remain exercisable.
  • [F6]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F7]All 9,597 options have vested and remain exercisable.
  • [F8]All 6,240 options have vested and remain exercisable.
  • [F9]The Reporting Person and his spouse are Co-Trustees of their successors in trust, of the McDonough-McGuire Joint Revocable Trust, dated May 14, 2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these ordinary shares in this report shall not be deemed an admission of beneficial ownership of all of the reported ordinary shares for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

Quotient Ltd

CIK 0001596946

→
Entity typeother

Related Parties

1
  • filerCIK 0001605065

Filing Metadata

Form type
4
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 7:06 PM ET
Size
24.8 KB
View on SEC.gov